BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17010329)

  • 21. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
    Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.
    Tajouri L; Martin V; Ovcaric M; Curtain RP; Lea RA; Csurhes P; Pender MP; Griffiths LR
    Brain Res Bull; 2004 Jul; 64(1):9-13. PubMed ID: 15275951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of CD1A +622 T/C, +737 G/C and CD1E +6129 A/G genes polymorphisms with multiple sclerosis.
    Jamshidian A; Nikseresht AR; Vessal M; Kamali-Sarvestani E
    Immunol Invest; 2010; 39(8):874-89. PubMed ID: 20954848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis.
    Weber A; Wandinger KP; Mueller W; Aktas O; Wengert O; Grundström E; Ehrlich S; Windemuth C; Kuhlmann T; Wienker T; Brück W; Zipp F
    J Neuroimmunol; 2004 Apr; 149(1-2):195-201. PubMed ID: 15020080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.
    Otaegui D; Zuriarrain O; Castillo-Triviño T; Aransay A; Ruíz-Martinez J; Olaskoaga J; Marti-Masso J; Lopez de Munain A
    Mult Scler; 2009 Jan; 15(1):124-8. PubMed ID: 18755822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of single nucleotide polymorphisms of Nrf2 promoter region with susceptibility to vitiligo].
    Zhou MN; Xu AE; Lu LJ; Li YW; Zhao DK; Guan CP
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):969-72. PubMed ID: 18756969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for genetic factors associated with susceptibility to multiple sclerosis.
    Forte GI; Ragonese P; Salemi G; Scola L; Candore G; D'Amelio M; Crivello A; Di Benedetto N; Nuzzo D; Giacalone A; Lio D; Caruso C
    Ann N Y Acad Sci; 2006 May; 1067():264-9. PubMed ID: 16803996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.
    Mihailova S; Ivanova M; Mihaylova A; Quin L; Mikova O; Naumova E
    J Neuroimmunol; 2005 Nov; 168(1-2):138-43. PubMed ID: 16183136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis.
    Fenoglio C; Galimberti D; Ban M; Maranian M; Scalabrini D; Venturelli E; Piccio L; De Riz M; Yeo TW; Goris A; Gray J; Bresolin N; Scarpini E; Compston A; Sawcer S
    Neurosci Lett; 2006 Feb; 394(2):92-6. PubMed ID: 16257118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis.
    Kroner A; Mäurer M; Loserth S; Kleinschnitz C; Hemmer B; Rosche B; Toyka KV; Rieckmann P
    Tissue Antigens; 2004 Jul; 64(1):70-3. PubMed ID: 15191525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
    Sidoti A; Antognelli C; Rinaldi C; D'Angelo R; Dattola V; Girlanda P; Talesa V; Amato A
    Mult Scler; 2007 May; 13(4):446-53. PubMed ID: 17463067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations.
    Suppiah V; Goris A; Alloza I; Heggarty S; Dubois B; Carton H; Antigüedad A; Mendibe M; McDonnell G; Droogan A; Hawkins S; Graham C; Vandenbroeck K
    Int J Immunogenet; 2005 Dec; 32(6):383-8. PubMed ID: 16313303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
    Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
    J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
    Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
    Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population.
    Wiśniewski A; Bilińska M; Klimczak A; Wagner M; Majorczyk E; Nowak I; Pokryszko-Dragan A; Kuśnierczyk P
    Int J Immunogenet; 2010 Aug; 37(4):307-11. PubMed ID: 20636826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population.
    Heidari M; Behmanesh M; Sahraian MA
    Immunol Invest; 2011; 40(3):279-89. PubMed ID: 21190413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
    Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis.
    Schmidt S; Papassotiropoulos A; Sotgiu S; Kölsch H; Arru G; Fois ML; Haase CG; Schmitz S; König N; Harzheim M; Heun R; Klockgether T
    J Neurol; 2003 May; 250(5):607-11. PubMed ID: 12736743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population.
    Urcelay E; Blanco-Kelly F; de Las Heras V; de la Concha EG; Arroyo R; Martínez A
    J Neuroimmunol; 2007 Dec; 192(1-2):215-8. PubMed ID: 17967488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.